Live Breaking News & Updates on Mumbai Based Parikh

On Tuesday, private equity firm Advent International acquired the entire stake in the company
In 2008, when FMCG major Emami Group took over Zandu Pharmaceuticals from Mumbai-based Parikh family, 22-year-old Nihar Parikh decided to buyback Zandu Chemicals, a subsidiary, and carve it out into a separate firm. Little did he know that his initial investment of ₹12.5 crore would multiply 160 times to fetch him a whopping ₹2,000 crore in just 12 years.
On Tuesday, private equity firm Advent International acquired the entire stake in ZCL Chemicals Ltd (formerly known as Zandu Chemicals Ltd) for about ₹2,000 crore, a move that also marked the exit of Morgan Stanley Private Equity Asia (MSPEA), which also sold its 19 per cent stake in the company. ....

Satish Khanna , Ajay Parikh , Nihar Parikh , Chemicals Ltd , Zandhu Pharmaceuticals , Zandu Pharmaceuticals , Us Food Drug Administration , Emami Group , Advent International , Zandu Chemicals Ltd , Mumbai Based Parikh , Zandu Chemicals , Morgan Stanley Private Equity Asia , Drug Administration , Manufacturing Practices , Zandu Chemical , Mumbai Based Lupin , Zcl Chemicals , சத்தீஷ் கண்ணா , அஜய பாறிக் , நிஹார் பாறிக் , இரசாயனங்கள் லிமிடெட் , ஜந்து மருந்துகள் , ஜந்து இரசாயனங்கள் லிமிடெட் , மும்பை அடிப்படையிலானது பாறிக் , ஜந்து இரசாயனங்கள் ,